Anja Krippner-Heidenreich

Years Active: 2023-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Martin Barajas, Milad Rasouli, Masayuki Umeda, Ryan Lea Hiltenbrand, Sherif Abdelhamed, Rebecca Mohnani, Bright Arthur, Tamara Westover, Melvin E Thomas, Mohieddin Jafari, Laura J Janke, Bei-Si Xu, Ti-Cheng Chang, Wojciech Rosikiewicz, Emily Xiong, Chandra Rolle, Jonathan Low, Reethu Krishnan, Guangchun Song, Michael P Walsh, Jing J Ma, Jeffrey E Rubnitz, Ilaria Iacobucci, Taosheng Chen, Anja Krippner-Heidenreich, Christian Michel Zwaan, Olaf Heidenreich, Jeffery M Klco
Acute myeloid leukemias with UBTF tandem duplications are sensitive to Menin inhibitors. Blood (2023)
Laura E Swart, Marcel H A M Fens, Anita van Oort, Piotr Waranecki, L Daniel Mata Casimiro, David Tuk, Martijn Hendriksen, Luca van den Brink, Elizabeth Schweighart, Cor Seinen, Ryan Nelson, Anja Krippner-Heidenreich, Tom O'Toole, Raymond M Schiffelers, Sander Kooijmans, Olaf Heidenreich
Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles. Pharmaceutics 15 (6) (2023)
Laura E Swart, Marcel H A M Fens, Anita van Oort, Piotr Waranecki, L Daniel Mata Casimiro, David Tuk, Martijn Hendriksen, Luca van den Brink, Elizabeth Schweighart, Cor Seinen, Ryan Nelson, Anja Krippner-Heidenreich, Tom O'Toole, Raymond M Schiffelers, Sander Kooijmans, Olaf Heidenreich
Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles. Pharmaceutics 15 (6) (2023)

Anja Krippner-Heidenreich.css-eqlu8i{font-size:small;padding-left:4px;}